Module 16 Flashcards
Congenital Lactose Intolerance
Deficiency in b-galactosidase
B-galactosidase
Digestion of disaccharide lactose
Lactose Intolerance Help
Intake of fermented dairy instead of milk so LAB produce B-galacotsidase to breakdown lactose in intestine or milk
B-galactosidase not function
Lactose makes CS of intestine secrete water into intestine and lots of bacterial fermentation –> Production of H, CO2, lactic acid, and acetic acid –> loose stool, bloating, abdominal pain, flatulence
Types of Diarrhea Treatments
Infantile, Antibiotic-associated, Traveller’s
Infantile diarrhea
Several viruses and bacteria but mainly rotavirus
Leading cause of acute viral gastroenteritis in children
Group A Rotavirus (GVA) at about 440,000 deaths/year
GVA Mechanism
Enhanced permeability of gut epithelial cells to intact proteins and altered handling of antigens in enteric route
Steps of RVA
Increased permeability of intestinal wall –> More antigens across barrier –> Bigger inflammatory response
Why probiotics might help with GVA
Enhance mucosal integrity
GVA in animal models
Rodents and Pigs
Bacteria against RVA
Lactobacilli casie sp. rhamnosus strain GG and Bifidobacteria bifidum
Antibiotic-Associated Diarrhea
Otherwise unexplained diarrhea that occurs in association with antibiotics
Pseudomembranous colitis
C. diff etiological agent
Most common cause of antibiotic-associated diarrhea
C. diff
Antibiotics…
Disrupts barrier function of normal microbiota so C. diff can establish itself and produce toxin
Antibiotics for C. diff
Metronidazole and Vancomycin with recurrence common
Probiotics Prevention of C. diff
Conflict with B. longum superior to placebo for erythromycin induced diarrhea in 10 healthy and L. GG having lower incidence compared with yogurt placebo
Probiotic for C. diff
Lactobacillus GG
Treatment for C. diff times
Ongoing infection or while on antibiotics
Psuedomembraneous colitis mechanism
Exaggerated response of circulating neutrophils and monocytes due to toxin –> inflamed intestinal tissue and cell death
Traveler’s diarrhea
Many microbes but most caused by enterotoxigenic E. coli from drinking water in different countries
Results of probiotics in TD
Conflict depending on strain, vehicle, and dosage (hard to evaluate)
Prevalence of H. pylori gastritis
50% worldwide
Chronic gastritis
H. pylori
Increased risk of peptic ulcer disease
H. pylori
Increased H. pylori cancers
MALT lymphoma and Gastric Cancer
Probiotics for H. pylori
Improve eradication with other anti-therapies and decrease antibiotic related side effects
Mechanisms that treat H. pylori
(1) AM substance production
(2) Epithelial cell adhesion and competition
(3) Mucosal barrier stabilization
(4) IR regulation
(5) sIgA secretion
AM substance production to treat H. pylori
Bifidobacterium and Enterococcus generate heat stable protein
Mucosal barrier stabilization
Tight junction strengthened so pathogen cannot get through
Immune response regulation for H. pylori
Probiotics stimulate –> pathogen gets there –> quick IR to clear
First line of tolerance
sIgA Secretion
For H. pylori treatment
Combo of probiotics more effective in eradication or big proportion elimination
Necrotizing Enterocolitis (NEC)
Acute inflammation due to immature intestine that effects 5-10% of low birth rate infants
NEC leads to…
High mortality, heavy complication, invalidating sequelae
Immaturity of Intestinal barrier
Likely major etiological factors of NEC
Probiotics of NEC
Any microbe can invade so any bacteria that can strengthen the intestinal barrier
Most probiotic trials on NEC
Focus on impact of intestinal colonization measured by fecal microbiota composition analysis
Probiotics for NEC
Variety or mix of strains or synbiotics reduce level of pathogenic bacteria and yeast
L. reuteri ATCC 55730
Accelerate GI motility to prevent bacterial overgrowth in NEC
B. lactis SNSM I-33446
Faster decrease of intestinal permeability levels in NEC –> preterm barrier function
Most trials on NEC focus on
Microbiota to determine if it’s the agent of disease
IBS
GI disorder characterised by association between recurrent abdominal pain/discomfort and change in stool consistency and frequency
IBS categories by symptoms in subgroup
Constipation-predominant, Diarrhea-predominant, Mixed type
IBS Cause
Deregulated IR directly related to deterioration of intestinal barrier function
Microbiota in IBS
Debate but microbiota likely involved in disease symptoms
How microbiota contributes to IBS
(1) Altered fermentation
(2) Harmful modulation of enteric sensorimotor function
(3) Impair intestinal barrier function
(4) Sustained Immune activation without macroscopic signs of inflammation
(5) Harmful modulation of the brain-gut axis
IBS symptom score probiotics
Those that increase barrier function
IBS has
Lots of scientific debate
Chicken or egg approach for
Microbiota causing intestinal barrier disruption in IBS or otehr way
Disruption of barrier causes
Inflammation and sustained IR
IBS probiotic studies
Mostly in vitro and ex vivo cell culture + animal models such as mice and rats
IBS studies work by
Disrupting the intestinal barrier before adding probiotic strain or a mixture
Probiotics in IBS can lead to…
Alleviation of symptoms in animals + restoration of barrier function by enhancing tight junction proteins
Tight junction proteins
Occludin, E-cadherin, Claudin-1
Tight junction proteins produced to help
IBS to enhance barrier function
Lost of probiotics and mixtures tested
IBS
IBD overall term to describe
CD and UC and Pouchitis
Affect any part of bowel but predominately terminal ileum and colon
Chron’s Disease
Granulomatous, patchy, transmural mononuclear inflammation
CD
Only affects the colon
UC
Lesions mucosal and continuous
UC
UC
Massive neutrophil infiltration, crypt abscesses, loss of goblet cells, epi damage
Acute or chronic inflammation of ileal reservoir
Pouchitis
Pouchitis
After colectomy and ileal pouch-anal anastomosis following UC
Active IBD
Mucosal inflammation + impaired barrier function
Remission of CD and UC Requires
Immunosuppressive agents such as corticosteroids, azathioprine, and anti-TNF
Probiotics not tested on
Active IBD
Probiotics in IBD
Maintaining remission
Probiotics for IBD Treated for…
Pouchitis mostly, some UC, unlikely CD
Probiotics in constipation
Reduce whole gut transit time and increased stool frequency
Probiotic microbes in constipation
Bifidobacterium lactis but not L. casei Shirota
Cancer prevention and proboitics
Changes related to tumor induction and promotion
Cancer prevention mechanisms
- Alter intestinal microecology (microbiota effect)
- Altered intestinal metabolic activity
- Normalize intestinal permeability
- Enhanced intestinal immunity
- Strengthened intestinal barrier mechanisms
Altered Microecology (Microbiota effect)
Remove from the microbiome microbes that have ability to turn pro-carcinogens to carcinogens
Cancer prevention mostly…
Removal of cancer promoting compounds or inhibition of transformation of non-carcinogens into carcinogens
Strengthen intestinal Barrier through
Altering microecology + Altered metabolic activity + normalize intestinal permeability + enhance intestinal immunity
Specific Examples of LAB in Cancer prevention
(1) Bind mutagenic amines generated when cooking protein rich food
(2) Degrade nitrosamines
(3) Reduce activity of bacterial B-glucuronidaes, nitroreductases, adn azoreductases
(3) Inhibit quinoline (IQ) induced incidence of colon tumors in rats
(4) Bind aflatoxins (fungal endotoxins that are pro-carcinogens) so they cannot be adsorbed by the intestine
2-amino-3-methylimidazol [4,5-f] quinoline (IQ)
Induce intestinal tumors
Detrimental to dental health
Sugar fermentation and pH decreases + high buffering capacity of milk products and calcium concentrations that help in protection of dental surfaces
Preventative effect of fermented milks and cheeses
Lactobacillus GG colonize oral mucosa and prevent growth of S. sorbinus + S. mutants
Nutritional absorption + Specialized barrier function
Intestinal mucosa
Front line of intestinal barrier
Single layer of specialized epithelial cells linked together by tight junction proteins (TJ)
Factors that support intestinal barrier
Mucins, AM molecules, Immunoglobulins, cytokines
Enterocytes
Specialised epithelial cells of the intestine that form single barrier with tight junctions
Leaky gut
Barrier factor abnormalities causes intestinal permeability
Paneth Cells
Secrete antimicrobial molecules
Goblet Cells
Produce mucus
Lamina propria
Layer right under epithelial cells that has cells that sense the exterior or secrete IgA with AM activity
Leaky gut problems
Microbes or toxins get accross –> exaggerated IR
Leaky gut leads to
Autoimmune diseases due to antigens entering the gut lumen –> local and systemic immune responses
Diseases arise or exacerbated due to leaky gut
IBD, Celiac disease, Autoimmune hepatitis, T1D, MS, SLE
Requirements for gut derived systemic IR
TLR activation + inflammasome stimulation + Dysbiosis + Molecular mimicry + Breech of barrier
Inflammasome
Protein complexes in different cells that induce secretion of IL1B and IL-18
Molecular mimicry
Antigens similar to our own is original target for the IR so antibodies get directed against our own cells
Chronic immune-mediated inflammatory liver disease with uncertain cause
Autoimmune Hepatitis
Susceptibility factor of autoimmune hepatitis
MHC
Key antigen targets for autoimmune hepatitis
Cytochrome P450 2D6 (CYP2D6) + formiminotransferase cylcodeaminase
Molecular mimicry example
CYP2D6 and HCV, HSV, CMV –> autoimmune hepatitis
Steps to AI Hepatitis
Dysbiosis of intestine –> bacterial ligands and toxins get into bloods stream –> to liver through portal veins –> activate T-cells –> exacerbate responses or activation of inflammasome –> Inflammation, liver damage, hepatic fibrosis
AI associated with…
Dysbiosis evidenced by proteins binding intestinal epithelial cells being reduced in patients with A disease + LPS increased + decreased intestinal anaerobes (Bifidobacterium and Lactobacillus)
Structural proteins reduced in AI hepatits
Zona occludens 1 and occludin
AI and probiotics
Not addressed yet due to no animal model
Severe persistent inflammation that leads to tissue damage of multiple organs
Systemic Lupus Erythematosus
Women are … more likely to get SLE
9x
SLE characterised by
Autoantibodies, auto reactive T-cells, Abnormal generation of proinflammatory cytokines
Therapeutic for SLE include
Restoring imbalanced cytokines and deficient immune cells
Triggers of SLE
Genetics, environment, unknown –> activation of IR against self Ag –> auto reactive B cells, pro cytokines, and inflammatory T cells
Inducers of SLE
LPS penetrated intestinal epithelium and translocating to tissues
Spontaneous development of lupus in mice
TLR4 increased induced by LPS
Treatment of SLE
Antibiotics to rid of commensal gut flora + Immunoregulatory probiotics
Immunoregulatory probioitcs
Enhance Treg cells and control inflammatory response –> induce tolerance
Before T1D disease onset
Impaired intestinal barrier functions (microbiome trigger)
Pancreatic B cells
Destroyed by autoimmunity in T1D
Zonulin
Pathogenic role of intestinal permeability in T1D depended on it; relies on bacterial colonization
Bacteria to T1D
Bacterial colonization –> Zonulin colonization –> increased intestinal permeability –> pathogenesis
Zonulin inhibitor in rats
Reversion of intestinal barrier dysbiosis relives symptoms of T1D
T1D faucets
Altered microbiota + leaky gut + altered mucosal immunity
T1D perfect storm
Altered microbiota —> exacerbated IR because increased presentation of antigen to APCs that get through the leaky gut —> T-cells activation —> cytokine relasesa nd secretion of autoantiboides in pancreas —> perfect storm because everything must act together for autoimmune reaction
Contributes to T1D development
Microbial Translocation
Streptozotocin-induced T1D
Gut bacteria able to translocate into PLNs and contribute to T1D + had a distinct microbiota
PLNs translocation proof
Treat streptozotocin mice with antibiotics –> PLNs sterile and disease attenuated